Analyst Interview News Today

If your team is looking to hire a sales analyst, these interview questions can help you find the right candidate to provide the data analysis you need.

Proactive Research analyst Richard Jeans presents his research on Alpha Financial Markets Consulting PLC (AIM:AFM) (LON:AFM).  Jeans says the firm...

After their IPSX London listing, Stacey tips Mailbox REIT, a single asset REIT, as one for investors to watch closely. The company owns The Mailbox, a...

Analysts upbeat on Vox Royalty Corps Nevada acquisition Proactive research analyst Ryan Long joined Stephen Gunnion to discuss Vox Royalty Corps (CVE:VOX) (OTCMKTS:VOXCF) planned US$1.98 million acquisition of a royalty on part of Gold Standard Ventures Corps (TSE:GSV) (NYSEAMERICAN:GSV) Railroad-Pinion gold project, which sits on the prolific Carlin Trend in Nevada. The project is advancing towards the completion of a feasibility study and a subsequent construction decision.  Long telling Pro...

Proactive analyst Emma Ulker talks to Proactive London about Open Orphan (LON:ORPH).  She says ORPH has firmly established its core pharma...

Open Orphan has firmly established its core pharma services offering Proactive analyst Emma Ulker talks to Proactive London about Open Orphan (LON:ORPH).  She says ORPH has firmly established its core pharma services offering, underpinned by the world-leading quarantine facilities, unique challenge study models and its established clinical trial services.  ORPH is focusing on converting an extensive and substantial amount of non-Covid-19 related services worth over £100mln. This is in additi...

TraceSafe: An emerging leader in the growing market for health and safety wearables TraceSafe (CNSX:TSF) is analysed by Proactives Ed Stacey with Presenter Katie Pilbeam.  He says wearable tech here to stay, on track for strong revenue growth for the full year 2021.  TraceSafe is an emerging leader in the growing market for health and safety wearables and the software that enables enterprises to customize and deploy these technologies.  The company recently reported revenues for the first q...

Proactive analyst Ed Stacey presents his analysis on Custodian REIT PLC (LON:CREI). The company recently announced an additional dividend for the last...

Maxcyte revenues rise 21%, hailing three new strategic licences with cell therapy developers Proactive Research analyst Emma Ulker discusses MaxCytes (LON:MXCT) commercial momentum across its cell therapy business, which led to 21% year-on-year top-line growth to US $26.2mln in fiscal (FY) 2020.  Ulker says this included three new strategic licences with high profile cell therapy developers, a fourth signed post period, a rise in recurring revenues from instrument leases and disposable sales i...

Aurania: Dynamics dramatically altered by upsurge in gold price Mining expert Christopher Ecclestone talks to Proactive London about Aurania (CVE:ARU- OTCQB:AUIAF) after his initiation of coverage just under a year ago, now taking a look at Auranias exploration programme and the recognition of this new district due to the successes of near neighbours such as Solaris. He says the dynamics have been dramatically altered by the upsurge in the gold price in 2020 and the copper price in 2021. And ma...